
Loading, please wait...

Loading, please wait...

Electroconvulsive therapy represents a vital, life-saving therapeutic modality for older adults presenting with treatment-resistant depression or life-threatening severe mood episodes. Nevertheless, clinicians frequently observe diverse confusional states during ECT that complicate geriatric neuropsychiatric care. Historically, neurocognitive research has focused primarily on retrograde and anterograde amnesia. However, acute and subacute confusional disturbances remain poorly understood, especially regarding their real-world incidence and natural history. Older patients possess reduced neurobiological reserve due to age-related cortical changes, microvascular subcortical pathology, and baseline cognitive frailty. Consequently, electrical seizure induction can precipitate acute neurobehavioral complications ranging from transient disorientation to prolonged interictal delirium. When severe confusion emerges, caregivers and clinical teams experience substantial distress. In addition, acute confusional episodes often trigger premature treatment cessation, resulting in depressive relapse and prolonged hospitalization. Understanding the full phenotypic spectrum of post-ECT confusion is therefore essential for clinicians managing geriatric depression. By implementing standardized neurocognitive tracking, healthcare providers can identify subtle cognitive vulnerabilities early. Furthermore, accurate phenotypic differentiation ensures that clinicians can manage emergent complications effectively while maintaining vital antidepressant efficacy for vulnerable older adults. Ultimately, balanced psychiatric care requires balancing profound mood recovery against acute cognitive safety.
To address critical knowledge gaps, researchers evaluated data from the prospective RECALL cohort study. This multicenter investigation enrolled 145 older adults aged 55 years or older presenting with a major depressive episode. All participants underwent clinical electroconvulsive therapy while researchers tracked neurocognitive parameters throughout the entire index course. Specifically, the investigators defined and measured five distinct subtypes of confusional states. These subtypes comprised postictal delirium, interictal delirium, postictal agitation, prolonged time to reorientation, and subacute general cognitive decline. The research team defined subacute cognitive decline as a reduction of at least four points on the Mini-Mental State Examination. Furthermore, clinical staff conducted assessments after individual treatment sessions to establish precise chronological sequences. This prospective design avoided retrospective charting errors and established reliable incidence figures. Consequently, the study provides clinicians with unprecedented clarity regarding adverse cognitive patterns in late-life depression. In addition, the findings highlight how varying cognitive vulnerabilities interact with repeated therapeutic seizures. Therefore, the RECALL dataset offers an essential empirical baseline for optimizing contemporary geriatric neurostimulation practices across psychiatric centers. These robust prospective methods illuminate clinical nuances that previous retrospective studies consistently overlooked.
The investigation revealed that confusional states during ECT occur with remarkable frequency among depressed geriatric patients. Overall, 55.9 percent of the older adults experienced at least one subtype of confusional state during their treatment. However, individual subtype rates demonstrated striking divergence across the study sample. Postictal agitation presented as the most prevalent complication, developing in 29.5 percent of treated patients. Similarly, prolonged time to reorientation affected 28.3 percent of the cohort, highlighting substantial recovery delay after seizure termination. In contrast, fully developed delirium syndromes occurred in smaller patient subsets. Postictal delirium emerged in 5.9 percent of older individuals, whereas interictal delirium developed in 4.2 percent. Furthermore, 18.0 percent of older adults suffered from more than one subtype of confusional state during therapy. These overlapping syndromes demonstrate that post-treatment confusion represents a heterogeneous spectrum rather than a uniform clinical entity. Consequently, psychiatric teams cannot rely on generic post-anesthesia checks to gauge recovery. Instead, clinicians must actively screen for specific behavioral and attentional abnormalities following each seizure. Thus, recognizing this high incidence enables timely intervention before severe cognitive disruption derails therapy. Early clinical recognition protects patient dignity and ensures therapeutic continuity throughout the treatment course.
A crucial clinical finding centers on the marked variation in recurrence across different confusional subtypes. Interictal delirium displayed the highest propensity for recurrence, returning in 66.7 percent of affected geriatric patients. Similarly, prolonged time to reorientation exhibited persistent recurrence, recurring in exactly 50.0 percent of affected older individuals. In contrast, postictal delirium recurred in only 12.5 percent of cases, suggesting a more transient neurobiological mechanism. Furthermore, investigators observed that confusional states emerged unpredictably at any point throughout the treatment series. Some participants experienced acute confusion after initial sessions, whereas others developed complications only after numerous treatments. Consequently, uneventful early sessions do not guarantee cognitive stability during later treatment phases. In addition, cumulative electrical exposure may progressively compromise fragile neural networks in susceptible elderly brains. Therefore, clinical teams must maintain persistent diagnostic vigilance throughout the entire therapeutic course. Providers should evaluate orientation and psychomotor behavior after every single session rather than easing surveillance protocols midway. Ultimately, recognizing these unpredictable trajectories empowers physicians to make timely adjustments to treatment schedules. Vigilant longitudinal monitoring remains the cornerstone of safe neurostimulation in geriatric medicine.
Managing post-treatment confusion requires practical procedural adjustments and enhanced diagnostic precision. When interictal delirium or prolonged reorientation emerges, clinicians should immediately re-evaluate electrical stimulation parameters. For instance, switching from bitemporal to right unilateral ultrabrief stimulus delivery markedly reduces cognitive adverse effects. In addition, spacing treatment sessions further apart allows vulnerable neural networks to recover metabolic equilibrium. Psychiatrists must also review concurrent psychotropic regimens with extreme care. Specifically, reducing anticholinergic medications and tapering high-dose benzodiazepines minimizes additive encephalopathic risk. Furthermore, medical teams must promptly investigate systemic triggers such as occult urinary tract infections, metabolic disturbances, or dehydration. The study authors also emphasized that standard cognitive instruments lack sensitivity for acute post-seizure encephalopathy. Traditional tools like the Mini-Mental State Examination fail to capture dynamic fluctuations in arousal and psychomotor agitation. Therefore, developing standardized, ECT-specific assessment batteries represents an urgent research priority. In the interim, multidisciplinary collaboration between psychiatrists, geriatricians, and anesthesiologists remains vital. By combining individual stimulus tailoring with systematic monitoring, clinicians can mitigate cognitive burden while successfully resolving late-life depressive episodes. Proactive clinical adaptations thereby sustain therapeutic efficacy while preserving cognitive wellbeing.
Prospective data reveal that 55.9 percent of older adults experience at least one confusional state during electroconvulsive therapy. Postictal agitation occurs in 29.5 percent of patients, while prolonged reorientation affects 28.3 percent. In contrast, formal postictal and interictal delirium occur less frequently, presenting in 5.9 percent and 4.2 percent of patients, respectively.
Interictal delirium exhibits the highest recurrence rate, returning in 66.7 percent of affected individuals. Prolonged time to reorientation also recurs frequently, manifesting in 50.0 percent of cases. Conversely, postictal delirium shows a low recurrence rate of only 12.5 percent, demonstrating that sustained encephalopathy presents a much higher clinical management risk.
Clinicians should immediately reduce treatment frequency by spacing ECT sessions further apart. In addition, switching electrode placement from bitemporal to right unilateral ultrabrief stimulation minimizes cognitive toxicity. Physicians must also taper anticholinergic or sedative medications, evaluate systemic medical contributors, and allow sufficient neurocognitive recovery between successive electrical treatments.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A prospective cohort study of 145 older adults with depression found that over half experienced confusional states during ECT. Postictal agitation and prolonged reorientation were most prevalent, while interictal delirium showed the highest recurrence rate, highlighting the need for vigilant clinical monitoring.
Today

Novel glucose-responsive mPEG-PSA nanocarriers deliver insulin aspart on demand, achieving dual postprandial and basal glycemic control without hypoglycemia in diabetic models. This biomaterial breakthrough offers promising clinical implications for physiologic diabetes management.
Today

A novel folate-conjugated tecto-dendrimer nanoplatform successfully delivers siRNA to achieve targeted HK2 silencing, disrupting ovarian cancer glycolysis and suppressing lactate output.
Today

A comparative non-contact study reveals that high-power radiofrequency delivery with the QDOT MICRO catheter induces an artifactual contact force rise. Electrophysiologists must understand this power-dependent thermal and electrical phenomenon to avoid inadvertent catheter withdrawal and ineffective ablation.
Today

A novel proof-of-concept study presents a six-degree-of-freedom articulated manikin neck equipped with linear potentiometers. The system provides real-time kinematic motion feedback during cervical immobilisation, delivering sub-degree tracking accuracy to improve pre-hospital trauma training and patient safety.
Today

A retrospective comparative cohort study evaluated genitourinary safety in HFpEF between dapagliflozin and empagliflozin over six months. Rates of symptomatic UTI and asymptomatic bacteriuria showed no statistically significant differences, supporting comparable safety profiles across both SGLT2 inhibitors.
Today